Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

1.

From research to the real world: buprenorphine in the decade of the Clinical Trials Network.

Ling W, Jacobs P, Hillhouse M, Hasson A, Thomas C, Freese T, Sparenborg S, McCarty D, Weiss R, Saxon A, Cohen A, Straus M, Brigham G, Liu D, McLaughlin P, Tai B.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S53-60. doi: 10.1016/j.jsat.2010.01.009.

PMID:
20307796
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.

Yokell MA, Zaller ND, Green TC, Rich JD.

Curr Drug Abuse Rev. 2011 Mar;4(1):28-41. Review.

PMID:
21466501
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.

Mammen K, Bell J.

Expert Opin Pharmacother. 2009 Oct;10(15):2537-44. doi: 10.1517/14656560903213405. Review.

PMID:
19708849
[PubMed - indexed for MEDLINE]
4.

Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence.

Orman JS, Keating GM.

Drugs. 2009;69(5):577-607. doi: 10.2165/00003495-200969050-00006. Review.

PMID:
19368419
[PubMed - indexed for MEDLINE]
5.

Buprenorphine in the treatment of opiate dependence: its pharmacology and social context of use in the U.S.

Wesson DR.

J Psychoactive Drugs. 2004 May;Suppl 2:119-28. Review.

PMID:
15279124
[PubMed - indexed for MEDLINE]
6.

Buprenorphine and naloxone for heroin dependence.

Johnson RE, McCagh JC.

Curr Psychiatry Rep. 2000 Dec;2(6):519-26. Review.

PMID:
11123005
[PubMed - indexed for MEDLINE]
7.

Opioid dependence treatment, including buprenorphine/naloxone.

Raisch DW, Fye CL, Boardman KD, Sather MR.

Ann Pharmacother. 2002 Feb;36(2):312-21. Review.

PMID:
11847954
[PubMed - indexed for MEDLINE]
8.

Practical considerations for the clinical use of buprenorphine.

Jones HE.

Sci Pract Perspect. 2004 Aug;2(2):4-20. Review.

PMID:
18552728
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Buprenorphine maintenance: a new treatment for opioid dependence.

Collins GB, McAllister MS.

Cleve Clin J Med. 2007 Jul;74(7):514-20. Review.

PMID:
17682629
[PubMed - indexed for MEDLINE]
Free Article
10.

Narrative review: buprenorphine for opioid-dependent patients in office practice.

Sullivan LE, Fiellin DA.

Ann Intern Med. 2008 May 6;148(9):662-70. Review.

PMID:
18458279
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Buprenorphine for office-based practice: consensus conference overview.

Kosten TR, Fiellin DA; U.S. National Buprenorphine Implementation Program.

Am J Addict. 2004;13 Suppl 1:S1-7. Review.

PMID:
15204671
[PubMed - indexed for MEDLINE]
12.

Buprenorphine: how to use it right.

Johnson RE, Strain EC, Amass L.

Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S59-77. Review.

PMID:
12738351
[PubMed - indexed for MEDLINE]
13.
14.

Buprenorphine-containing treatments: place in the management of opioid addiction.

Robinson SE.

CNS Drugs. 2006;20(9):697-712. Review.

PMID:
16953647
[PubMed - indexed for MEDLINE]
15.

Buprenorphine for the treatment of opioid dependence.

Boothby LA, Doering PL.

Am J Health Syst Pharm. 2007 Feb 1;64(3):266-72. Review.

PMID:
17244875
[PubMed - indexed for MEDLINE]
16.

The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic.

Walsh SL, Eissenberg T.

Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S13-27. Review.

PMID:
12738347
[PubMed - indexed for MEDLINE]
17.

Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?

Mendelson J, Jones RT.

Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S29-37. Review.

PMID:
12738348
[PubMed - indexed for MEDLINE]
18.

Consensus statement on office-based treatment of opioid dependence using buprenorphine.

Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR.

J Subst Abuse Treat. 2004 Sep;27(2):153-9. Review.

PMID:
15450648
[PubMed - indexed for MEDLINE]
19.

Bupreorphine:a new pharmacotherapy for opioid addictions treatment.

Stock C, Shum JH.

J Pain Palliat Care Pharmacother. 2004;18(3):35-54. Review.

PMID:
15364630
[PubMed - indexed for MEDLINE]
20.

Safety and health policy considerations related to the use of buprenorphine/naloxone as an office-based treatment for opiate dependence.

Bridge TP, Fudala PJ, Herbert S, Leiderman DB.

Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S79-85. Review.

PMID:
12738352
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk